128 related articles for article (PubMed ID: 22691126)
1. Epidemiology of dermatofibrosarcoma protuberans in Alberta, Canada, from 1988 to 2007.
Kuzel P; Metelitsa AI; Dover DC; Salopek TG
Dermatol Surg; 2012 Sep; 38(9):1461-8. PubMed ID: 22691126
[TBL] [Abstract][Full Text] [Related]
2. Dermatofibrosarcoma protuberans: a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002.
Monnier D; Vidal C; Martin L; Danzon A; Pelletier F; Puzenat E; Algros MP; Blanc D; Laurent R; Humbert PH; Aubin F
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1237-42. PubMed ID: 17062038
[TBL] [Abstract][Full Text] [Related]
3. Dermatofibrosarcoma protuberans: a clinicopathological study in an African population.
Mbonde MP; Amir H; Kitinya JN
East Afr Med J; 1996 Jun; 73(6):410-3. PubMed ID: 8840606
[TBL] [Abstract][Full Text] [Related]
4. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.
Snow SN; Gordon EM; Larson PO; Bagheri MM; Bentz ML; Sable DB
Cancer; 2004 Jul; 101(1):28-38. PubMed ID: 15221986
[TBL] [Abstract][Full Text] [Related]
5. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
[TBL] [Abstract][Full Text] [Related]
6. Risk of subsequent primary malignancies after dermatofibrosarcoma protuberans diagnosis: a national study.
Kurlander DE; Martires KJ; Chen Y; Barnholtz-Sloan JS; Bordeaux JS
J Am Acad Dermatol; 2013 May; 68(5):790-6. PubMed ID: 23261548
[TBL] [Abstract][Full Text] [Related]
7. Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans.
Martin L; Piette F; Blanc P; Mortier L; Avril MF; Delaunay MM; Dréno B; Granel F; Mantoux F; Aubin F; Sassolas B; Adamski H; Dalac S; Pauwels C; Dompmartin A; Lok C; Estève E; Guillot B;
Br J Dermatol; 2005 Nov; 153(5):932-6. PubMed ID: 16225602
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Outcomes of Dermatofibrosarcoma Protuberans in the US Pediatric Population.
Rubio GA; Alvarado A; Gerth DJ; Tashiro J; Thaller SR
J Craniofac Surg; 2017 Jan; 28(1):182-184. PubMed ID: 27922973
[TBL] [Abstract][Full Text] [Related]
9. A population-based study of cutaneous melanoma in Alberta, Canada (1993-2002).
Metelitsa AI; Dover DC; Smylie M; de Gara CJ; Lauzon GJ
J Am Acad Dermatol; 2010 Feb; 62(2):227-32. PubMed ID: 20018405
[TBL] [Abstract][Full Text] [Related]
10. Hormone receptor expression in patients with dermatofibrosarcoma protuberans.
Kreicher KL; Honda KS; Kurlander DE; Bordeaux JS
J Am Acad Dermatol; 2016 Dec; 75(6):1205-1209. PubMed ID: 27542587
[TBL] [Abstract][Full Text] [Related]
11. Incidence and Survival of Primary Dermatofibrosarcoma Protuberans in the United States.
Kreicher KL; Kurlander DE; Gittleman HR; Barnholtz-Sloan JS; Bordeaux JS
Dermatol Surg; 2016 Jan; 42 Suppl 1():S24-31. PubMed ID: 26730971
[TBL] [Abstract][Full Text] [Related]
12. Pediatric dermatofibrosarcoma protuberans in Madrid, Spain: multi-institutional outcomes.
Valdivielso-Ramos M; Torrelo A; Campos M; Feito M; Gamo R; Rodriguez-Peralto JL
Pediatr Dermatol; 2014; 31(6):676-82. PubMed ID: 25424208
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous soft tissue sarcoma incidence patterns in the U.S. : an analysis of 12,114 cases.
Rouhani P; Fletcher CD; Devesa SS; Toro JR
Cancer; 2008 Aug; 113(3):616-27. PubMed ID: 18618615
[TBL] [Abstract][Full Text] [Related]
14. Dermatofibrosarcoma protuberans: how wide should we resect?
Farma JM; Ammori JB; Zager JS; Marzban SS; Bui MM; Bichakjian CK; Johnson TM; Lowe L; Sabel MS; Wong SL; Douglas Letson G; Messina JL; Cimmino VM; Sondak VK
Ann Surg Oncol; 2010 Aug; 17(8):2112-8. PubMed ID: 20354798
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Survival Outcomes of Dermatofibrosarcoma Protuberans From 2000 to 2020: A Population-Based Retrospective Cohort Analysis.
Xiong DD; Bordeaux JS
Dermatol Surg; 2023 Dec; 49(12):1096-1103. PubMed ID: 37962980
[TBL] [Abstract][Full Text] [Related]
16. Plaque-like CD34-positive dermal fibroma ("medallion-like dermal dendrocyte hamartoma"): clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma protuberans.
Kutzner H; Mentzel T; Palmedo G; Hantschke M; Rütten A; Paredes BE; Schärer L; Guillen CS; Requena L
Am J Surg Pathol; 2010 Feb; 34(2):190-201. PubMed ID: 20061935
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of dermatofibrosarcoma protuberans in head and neck].
Ni S; Xu ZG; Wang XL; Liu SY; Lu N; Xue LY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Jun; 42(6):404-7. PubMed ID: 17702411
[TBL] [Abstract][Full Text] [Related]
18. Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.
Bowne WB; Antonescu CR; Leung DH; Katz SC; Hawkins WG; Woodruff JM; Brennan MF; Lewis JJ
Cancer; 2000 Jun; 88(12):2711-20. PubMed ID: 10870053
[TBL] [Abstract][Full Text] [Related]
19. Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate.
Fiore M; Miceli R; Mussi C; Lo Vullo S; Mariani L; Lozza L; Collini P; Olmi P; Casali PG; Gronchi A
J Clin Oncol; 2005 Oct; 23(30):7669-75. PubMed ID: 16234529
[TBL] [Abstract][Full Text] [Related]
20. Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005.
Pruthi DK; Guilfoyle R; Nugent Z; Wiseman MC; Demers AA
J Am Acad Dermatol; 2009 Jul; 61(1):44-50. PubMed ID: 19395122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
